GlassScriptPhysician profile
Sameer A Syed
NPI 1083933089
$11,768.22
in general payments reported to CMS, 2019-2025
43 companies · $2,315 in 2025
The $2,315 reported for 2025 was more than what 85% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,786 · 2020: $821 · 2021: $1,000 · 2022: $590 · 2023: $1,343 · 2024: $3,913 · 2025: $2,315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,809 · Travel and Lodging: $762.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,808.50 |
| Travel and Lodging | $762.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,610.87 | 2021-2025 | Intellis Adaptivestim, Synchromedii |
| Boston Scientific Corporation | $1,116.72 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Abbvie INC. | $882.55 | 2021-2025 | Qulipta, Botox, Ubrelvy |
| Abbott Laboratories | $867.12 | 2019-2025 | Eterna, Octrode, Proclaim |
| Biotronik Nro, INC. | $628.53 | 2024-2025 | Prospera |
| Pfizer INC. | $555.65 | 2019-2025 | |
| Nevro Corp. | $549.05 | 2023-2024 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $510.17 | 2020-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $477.52 | 2019-2025 | Xtampza |
| Scilex Pharmaceuticals INC. | $352.04 | 2019-2025 | Ztlido |
| Teva Pharmaceuticals USA, INC. | $343.19 | 2019-2022 | |
| Biohaven Pharmaceuticals, INC. | $263.83 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $233.10 | 2019-2021 | |
| Saluda Medical Americas, INC. | $226.55 | 2025 | Evoke |
| Foundation Fusion Solutions, LLC | $209.14 | 2023 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $168.40 | 2025 | Ha Minuteman G3-R |
| Medtronic USA, INC. | $163.53 | 2019-2020 | |
| Epimed International, INC | $153.90 | 2019 | |
| Azurity Pharmaceuticals, INC. | $143.43 | 2024-2025 | Horizant |
| Biohaven Pharmaceutical Holding Company LTD. | $133.78 | 2022 | |
| Biodelivery Sciences International, INC. | $129.91 | 2021 | |
| Curonix LLC | $129.71 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Vertos Medical, INC. | $114.38 | 2022 | |
| Lundbeck LLC | $99.47 | 2023-2025 | Vyepti |
| Horizon Therapeutics Plc | $85.89 | 2019-2022 | |
| Lilly USA, LLC | $72.82 | 2019-2021 | |
| Valinor Pharma, LLC | $68.05 | 2025 | Movantik |
| Nalu Medical, INC. | $66.93 | 2024 | Nalu Neurostimulation System |
| Bioventus LLC | $60.69 | 2022-2024 | Durolane, Durolane |
| Tonix Medicines, INC. | $45.17 | 2025 | Tonmya |
| Amgen INC. | $41.83 | 2019-2020 | |
| Mml US, INC. | $39.52 | 2025 | Reactiv8 |
| Hydrocision, INC. | $34.51 | 2025 | Tenjet |
| Globus Medical, INC. | $28.34 | 2025 | Senza |
| Integra Lifesciences Corporation | $26.92 | 2021 | |
| Upsher-Smith Laboratories LLC | $23.03 | 2020 | |
| Fidia Pharma USA INC. | $22.21 | 2024 | Triluron, Hymovis, Hyalgan |
| Allergan, INC. | $19.26 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $17.58 | 2019 | |
| Assertio Therapeutics, INC. | $16.31 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.64 | 2022 | |
| Spr Therapeutics, INC | $12.28 | 2024 | Sprint Pns System |
| Indivior INC. | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Syed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.